The trajectory of copyright's flagship drug presents a nuanced case for investors in the medicinal sector. While initially a tremendous success, creating vast sums, the patent end and the subsequent arrival of generic https://pharma553680.dbblog.net/15099320/sildenafil-and-the-pharmaceutical-industry-a-speculative-bet